Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Drugs and closed-angle glaucoma risk].

D Pozzi1, C Giraud, M Callanquin

  • 1Service de Pharmacie, Hôpital Louis Mourier, 178, rue des Renouillers, 92701 Colombes Cedex, France.

Journal Francais D'Ophtalmologie
|April 20, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Characterisation of a major QTL for sodium accumulation in tomato grown in high salinity.

Plant, cell & environment·2024
Same author

Correction: Brain mapping across 16 autism mouse models reveals a spectrum of functional connectivity subtypes.

Molecular psychiatry·2022
Same author

Brain mapping across 16 autism mouse models reveals a spectrum of functional connectivity subtypes.

Molecular psychiatry·2021
Same author

[Lipemia retinalis: A rare manifestation of hypertriglyceridemia].

Journal francais d'ophtalmologie·2021
Same author

The liposome-protein corona in mice and humans and its implications for in vivo delivery.

Journal of materials chemistry. B·2020
Same author

Exploitation of nanoparticle-protein corona for emerging therapeutic and diagnostic applications.

Journal of materials chemistry. B·2020

Certain medications can trigger angle-closure glaucoma attacks in susceptible individuals. Awareness of drug contraindications and precautions is crucial for preventing these dangerous iatrogenic events.

Area of Science:

  • Ophthalmology
  • Pharmacology

Context:

  • Closed-angle glaucoma (CAG) is triggered by stimuli in predisposed individuals with narrow iridocorneal angles.
  • Iatrogenic causes are the most common, often linked to topical or systemic mydriatic drugs.

Purpose:

  • To identify and classify medications that pose a risk for inducing angle-closure glaucoma attacks.
  • To highlight the importance of understanding drug contraindications and precautions for preventing iatrogenic CAG.

Summary:

  • Specific drug classes, including those with anticholinergic, sympathomimetic alpha, and parasympathomimetic (anticholinesterase) activities, are identified as high-risk for precipitating CAG.
  • Medications are categorized by administration route and indication, with risk information detailed in product characteristics.

Related Experiment Videos

Impact:

  • Enhances clinical awareness regarding medication-induced angle-closure glaucoma.
  • Promotes safer prescribing practices by emphasizing the review of contraindications and precautions for at-risk patients.